Effect of Masked Uncontrolled Hypertension on Perioperative Haemodynamic Response and Recurrent Adverse Cardiovascular Events among Patients Undergoing Major Noncardiac Surgery
Abstract
Objective: To compare masked uncontrolled hypertension (MUCH) (n=16) and adequately controlled hypertension (ACH) (n=21) patients regarding their haemodynamic response to induction, incision and extubation, and evaluate the risk of perioperative recurrent adverse cardiovascular events in a prospective observational study.
Material and Methods: After home blood pressure (BP) monitoring, patients were classified as MUCH or ACH using objective criteria. Perioperative haemodynamic parameters were monitored. Recurrent adverse event risks were evaluated using total-time and gap-time recurrent-event analysis.
Results: BP responses to induction were qualitatively similar in the two groups, but with an exaggerated response following incision and extubation in the MUCH group. Risks of recurrent hypertensive events were higher in MUCH than in ACH patients during the intraoperative and emergence periods, with hazard ratios [95% confidence intervals] of 2.10 [1.21, 3.64] and 4.73 [1.12, 19.89] from total-time models, and 1.84 [1.20, 2.84] and 5.91 [1.45, 24.11] from gap-time models; the risk of recurrent bradycardia was higher during emergence, 4.08 [1.22, 13.59] from total-time and 4.88 [1.77, 13.45] from gap-time models. In contrast, the risk of recurrent hypotension was significantly lower in the MUCH patients during induction.
Conclusion: Compared to ACH, MUCH patients were at increased risk of recurrent hypertensive events during the intraoperative and emergence periods, and of recurrent bradycardia during emergence.
Keywords
Full Text:
PDFReferences
Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845–50.
Aronow WS. Management of hypertension in patients undergoing surgery. Ann Transl Med 2017;5:227.
Levin MA, Fischer GW, Lin HM, McCormick PJ, Krol M, Reich DL. Intraoperative arterial blood pressure lability is associated with improved 30 day survival. BJA Br J Anaesth 2015;115:716–26.
Forrest JB, Rehder K, Cahalan MK, Goldsmith CH. Multicenter study of general anesthesia. III. Predictors of severe perioperative adverse outcomes. Anesthesiol 1992;76:3–15.
Mascha EJ, Yang D, Weiss S, Sessler DI. Intraoperative mean arterial pressure variability and 30-day mortality in patients having noncardiac surgery. Anesthesiol 2015;123:79–91.
Monk TG, Bronsert MR, Henderson WG, Mangione MP, Sum- Ping STJ, Bentt DR, et al. Association between intraoperative hypotension and hypertension and 30-day postoperative mortality in noncardiac surgery. Anesthesiol 2015;123:307–19.
Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: A retrospective cohort analysis. Anesthesiol 2017;126:47–65.
Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiol 2013;119:507–15.
Saugel B, Sessler DI. Perioperative blood pressure management. Anesthesiol 2021;134:250–61.
Lizano-Díez I, Poteet S, Burniol-Garcia A, Cerezales M. The burden of perioperative hypertension/hypotension: a systematic review. PloS One 2022;17:e0263737.
Sessler DI, Bloomstone JA, Aronson S, Berry C, Gan TJ, Kellum JA, et.al. Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth 2019;122:563–74.
Lonjaret L, Lairez O, Minville V, Geeraerts T. Optimal perioperative management of arterial blood pressure. Integr Blood Press Control 2014;7:49–59.
Mohseni S, Behnam-Roudsari S, Tarbiat M, Shaker P, Shivaie S, Shafiee MA. Perioperative hypertension etiologies in patients undergoing noncardiac surgery in University Health Network Hospitals - Canada from 2015-2020. Integr Blood Press Control 2022;15:23–32.
Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291:1342–9.
Htay T, Rosado D, Quest D, Giller J, Haya N, Ream S, et al. Methods of blood pressure measurement to predict hypertension-related cardiovascular morbidity and mortality. Curr Cardiol Rep 2022;24:439–44.
Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press Monit 1999;4:303–317.
NICE hypertension guideline [homepage on the Internet]. New York: Medscape ;2019 [cited 2021 Nov 8]. Available from: https://www.guidelines.co.uk/cardiovascular/nicehypertension- guideline/454934.article.
Yue WW, Yin J, Chen B, Zhang X, Wang G, Li H, et al. Analysis of heart rate variability in masked hypertension. Cell Biochem Biophys 2014;70:201–04.
Sheng CS, Li FK, Cheng YB, Wei FF, Huang JF, Guo QH, et al. Blood pressure and heart rate variability and baroreflex sensitivity in white-coat, masked, and sustained hypertension. Hypertens Res 2020;43:772–80.
Song CL, Zhang X, Liu YK, Yue WW, Wu H. Heart rate turbulence in masked hypertension and white-coat hypertension. Eur Rev Med Pharmacol Sci 2015;19:1457–60.
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison HC, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension 2018;71:e13–e115.
Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, et.al. Card on behalf of the ES of HC and the ES of HWG on BPM and. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens 2021;39:1293–302.
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et.al The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019) Chapter 11. Treatment of hypertension under special conditions. Hypertens Res 2009;32:70–7.
Prentice RL, Williams BJ, Peterson AV. On the regression analysis of multivariate failure time data. Biometrika 1981;68:373–379.
Ozga AK, Kieser M, Rauch G. A systematic comparison of recurrent event models for application to composite endpoints. BMC Med Res Methodol 2018;18:2.
Amorim LD, Cai J. Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol 2015;44:324–333.
Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag 2008;4:615–27.
Prys-Rroberts C. Anaesthesia and hypertension. Br J Anaesth 1984;56:711-24.
Abdelgawad AF, Shi QF, Halawa MA, Wu ZL, Wu ZY, Chen XD, et al. Comparison of cardiac output and hemodynamic responses of intubation among different videolaryngoscopies in normotensive and hypertensive patients. J Huazhong Univ Sci Technol Med Sci 2015;35:432–8.
Kihara S, Brimacombe J, Yaguchi Y, Watanabe S, Taguchi N, Komatsuzaki T. Hemodynamic responses among three tracheal intubation devices in normotensive and hypertensive patients. Anesth Analg 2003;96:890–5.
Prys-Roberts C, Meloche R, Foëx P. Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients. Br J Anaesth 1971;43:122–37.
Lohmeier TE, Iliescu R. The baroreflex as a long-term controller of arterial pressure. Physiology 2015;30:148–58.
Nair VP, Hunter JM. Anticholinesterases and anticholinergic drugs. Contin Educ Anaesth Crit Care Pain 2004;4:164–8.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.